StockData

Endovia Health Sciences, Inc. (EDVA) stock

EDVANYSEBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.17−0.00 (-1.46%)

Close on Nov 17, 2026Market cap $126.28KP/E –Yield –

Endovia Health Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Endovia Health Sciences's operating income for the twelve months ending Jun 30, 2026 was -$13.51M. For fiscal 2025 it was -$14.19M. The highest annual figure on record is $66.68K in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.19M–
FY2024Dec 31, 2024-$9.90M–
FY2023Dec 31, 2023-$15.29M–
FY2022Dec 31, 2022-$21.39M–
FY2021Dec 31, 2021-$29.08M–
FY2020Dec 31, 2020-$17.66M–
FY2019Dec 31, 2019-$4.49M-6829.7%
FY2018Dec 31, 2018$66.68K–
FY2017Dec 31, 2017-$157.21K–
FY2016Dec 31, 2016-$50.00K-364.6%
FY2015Dec 31, 2015$18.90K–
FY2014Dec 31, 2014-$27.88K-4611.0%
FY2013Dec 31, 2013$618–
FY2012Dec 31, 2012-$9.32K–
FY2011Dec 31, 2011-$49.69K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.01M–
Q1 FY2026Mar 31, 2026-$978.97K–
Q4 FY2025Dec 31, 2025-$976.41K–
Q3 FY2025Sep 30, 2025-$9.54M–
Q2 FY2025Jun 30, 2025-$1.50M–
Q1 FY2025Mar 31, 2025-$1.66M–
Q4 FY2024Dec 31, 2024-$289.63K–
Q3 FY2024Sep 30, 2024-$2.67M–
Q2 FY2024Jun 30, 2024-$3.69M–
Q1 FY2024Mar 31, 2024-$3.25M–
Q4 FY2023Dec 31, 2023-$3.29M–
Q3 FY2023Sep 30, 2023-$4.32M–
Q4 FY2022Dec 31, 2022-$4.77M–
Q3 FY2022Sep 30, 2022-$5.11M–
Q2 FY2022Jun 30, 2022-$5.83M–
Q1 FY2022Mar 31, 2022-$5.68M–
Q4 FY2021Dec 31, 2021-$6.15M–
Q3 FY2021Sep 30, 2021-$12.07M–
Q2 FY2021Jun 30, 2021-$6.71M–
Q1 FY2021Mar 31, 2021-$4.55M–
Q4 FY2020Dec 31, 2020-$13.36M–
Q3 FY2020Sep 30, 2020-$2.16M–
Q2 FY2020Jun 30, 2020-$415.48K–
Q1 FY2020Mar 31, 2020-$1.55M–
Q4 FY2019Dec 31, 2019-$2.42M–
Q3 FY2019Sep 30, 2019-$861.60K–
Q2 FY2019Jun 30, 2019-$308.15K-550.0%
Q1 FY2019Mar 31, 2019-$448.48K-2911.3%
Q4 FY2018Dec 31, 2018-$15.55K–
Q3 FY2018Sep 30, 2018-$2.21K-106.7%
Q2 FY2018Jun 30, 2018$68.48K–
Q1 FY2018Mar 31, 2018$15.95K–
Q4 FY2017Dec 31, 2017-$107.45K–
Q3 FY2017Sep 30, 2017$33.07K–
Q2 FY2017Jun 30, 2017-$21.59K–
Q1 FY2017Mar 31, 2017-$61.24K–
Q4 FY2016Dec 31, 2016-$16.07K–
Q3 FY2016Sep 30, 2016-$12.23K–
Q2 FY2016Jun 30, 2016-$12.23K–

More Endovia Health Sciences figures

See a number that looks wrong?